ArticleClinical nuclear medicine2020

FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab.

Randy Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.